1 / 9

Asperitol (PB0182): Preliminary Results of Clinical Trial

Asperitol (PB0182): Preliminary Results of Clinical Trial. Kyle Evans Landon Pharmaceuticals Testing, Inc. LPT. Contents. Clinical Trial Client Company and Test Dates Medical Protocol Participant Demographics Medical Testing Results Summary and Recommendations. Clinical Trial.

fawzia
Télécharger la présentation

Asperitol (PB0182): Preliminary Results of Clinical Trial

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Asperitol (PB0182): Preliminary Results of Clinical Trial Kyle Evans Landon Pharmaceuticals Testing, Inc. LPT Landon Pharmaceuticals Testing

  2. Contents • Clinical Trial • Client Company and Test Dates • Medical Protocol • Participant Demographics • Medical Testing • Results • Summary and Recommendations Landon Pharmaceuticals Testing

  3. Clinical Trial • FDA Application Number 9284773-08 • Phase III Trial • Target disease: rheumatoid arthritis • Drug name: Asperitol • Drug code number PB0182 Landon Pharmaceuticals Testing

  4. Client Company and Test Dates • Contact information • Barbara Shao, Ph.D. • Parmerleau Biotechnologies • 105 Patriot Way • Newton, MA 02459 • Phone 402-555-4366 • Trial start date: February 12, 2008 • Trial completion date: September 15, 2010 Landon Pharmaceuticals Testing

  5. Medical Protocol • Standard double-blind protocol • Sites of clinical trials • New York City • Tampa, Florida • Lincoln, Nebraska • Sacramento, California • Pre-tested participants at clinics • Administered dosage: 20-mg pill • Bi-monthly medical tests of participants Landon Pharmaceuticals Testing

  6. Participant Demographics Landon Pharmaceuticals Testing

  7. Medical Testing • Joint fluid analysis • Blood tests • Radiographs (x-rays) • Patient-reported pain levels (10-point scale) Landon Pharmaceuticals Testing

  8. Results Landon Pharmaceuticals Testing

  9. Summary and Recommendation • Dramatic decrease of symptoms in females suggests that Asperitol could be a commercial success in treating rheumatoid arthritis among women • Moderate decrease of symptoms in males suggest that for some men, Asperitol could be effective • Parmerleau should apply to FDA for approval to do Phase IV clinical trial Landon Pharmaceuticals Testing

More Related